CD4 and neoplasm: The antitumor immune cells (such as activated CD4+ T cell and macrophages M1 cell) decreased in the high-risk group, but tumor tolerant immune cells (such as resting CD4+ T cell and macrophages M2 cell) increased in the tumor microenvironment (p<0.05, Figures 9F–J; Figure S4).